Bangladesh alone constituted about 45 per cent of total foreign tourist arrivals (FTAs) to India on medical visa in 2017, according to a FICCI study on ‘India: Innovating Transforming and Defining Medical Value Travel’. Bangladesh holds the eighth place among largest population countries in the world. The major destination countries include India, China, Singapore, Thailand, South Korea, Malaysia, Saudi Arabia, the USA, the UK, Australia, Japan and Germany for treatments including cardiology, oncology, neurology and orthopaedic. Majority of deaths in Bangladesh are due to non-communicable diseases out of which cancer has a share of 10 per cent. However, the existing infrastructure caters to approximately 10 per cent of cancer patients with 16 cancer treatment centres in Bangladesh. High costs, poor services, long waiting lists, lack of technology in Bangladesh are the major reasons for medical value travel from Bangladesh.